Silver Spring, MD — The Food and Drug Administration (FDA) authorized a second COVID-19 booster dose for some Americans on Tuesday.
A second booster of either the Pfizer or Moderna vaccines has been authorized for older and certain immunocompromised individuals. The FDA says new evidence suggests a second dose of the coronavirus booster improves protection against severe COVID-19 and isn’t associated with new safety concerns.
With the new changes in place, those 50 years and older can now get a second booster at least four months after receiving the first, or those immunocompromised individuals who are at least 12-years-old. The FDA’s new rules are only for the Pfizer and Moderna COVID vaccines.